Literature DB >> 21241242

Aripiprazole-induced pathological gambling: a report of 3 cases.

Julien Cohen1, David Magalon, Laurent Boyer, Nicolas Simon, Lançon Christophe.   

Abstract

We report three cases of pathological gambling induced by aripiprazole, in patients with schizophrenia or schizoaffective disorder. All three patients had no history of pathological gambling, and they started gambling after initiation of treatment with Aripiprazole. The fact that pathological behaviour disappears quickly as medication was ended suggests that an elaborate behavioral manifestation could be related to dopaminergic tone in patients with schizophrenia. We recommend consideration with increased attention for the appearance of pathological gambling symptoms among patients on Aripiprazole.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21241242     DOI: 10.2174/157488611794480016

Source DB:  PubMed          Journal:  Curr Drug Saf        ISSN: 1574-8863


  5 in total

1.  Management of common adverse effects of antipsychotic medications.

Authors:  T Scott Stroup; Neil Gray
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

Review 2.  Gambling disorder during dopamine replacement treatment in Parkinson's disease: a comprehensive review.

Authors:  Domenico Pirritano; Massimiliano Plastino; Domenico Bosco; Luca Gallelli; Antonio Siniscalchi; Giovambattista De Sarro
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

3.  Gambling Problems in Patients with Psychotic Disorders in Rural Greece.

Authors:  Vaios Peritogiannis; Panagiota Gioti; Afroditi Gogou
Journal:  J Neurosci Rural Pract       Date:  2020-05-02

4.  Drugs-Induced Pathological Gambling: An Analysis of Italian Spontaneous Reporting System.

Authors:  Cristina Scavone; Barbara Stelitano; Concetta Rafaniello; Francesco Rossi; Liberata Sportiello; Annalisa Capuano
Journal:  J Gambl Stud       Date:  2020-03

Review 5.  Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review.

Authors:  Marie Grall-Bronnec; Anne Sauvaget; Fanny Perrouin; Juliette Leboucher; François Etcheverrigaray; Gaëlle Challet-Bouju; Louise Gaboriau; Pascal Derkinderen; Pascale Jolliet; Caroline Victorri-Vigneau
Journal:  J Clin Psychopharmacol       Date:  2016-02       Impact factor: 3.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.